Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €2.57 EUR
Change Today -0.039 / -1.49%
Volume 0.0
EZB On Other Exchanges
Symbol
Exchange
Munich
As of 3:03 AM 07/3/15 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

527 Madison Avenue

New York, NY 10022

United States

Phone: 212-583-0100

Fax:

Enzo Biochem, Inc., an integrated life sciences and biotechnology company, engages in the research, development, manufacture, and marketing of diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. Segments The company includes three segments: Clinical Labs, Life Sciences, and Therapeutics. Enzo Clinical Labs is a regional clinical reference laboratory serving the New York, New Jersey, and Eastern Pennsylvania medical communities. Enzo Clinical Labs offers a menu of routine and esoteric clinical laboratory tests or procedures used in general patient care by physicians to establish or support a diagnosis, monitor treatment or medication, and search for an otherwise undiagnosed condition. The company operates a full-service clinical laboratory in Farmingdale, New York; a network of approximately 35 patient service centers throughout New York and New Jersey; a stand-alone ‘stat’ or rapid response laboratory in New York City; and a full-service phlebotomy, in-house logistics department and information technology department. Enzo Life Sciences manufactures, develops, and markets products and tools to life sciences, drug development and clinical research customers worldwide. The company’s portfolio of proteins, antibodies, peptides, small molecules, labeling probes, dyes and kits, which are proprietary, provides life science researchers tools for target identification/validation, high content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis. The company manufactures, in-licenses, and commercializes approximately 9,000 of its own products and in addition distributes 40,000 products made by 40 other original manufacturers. Enzo Therapeutics is a biopharmaceutical venture that has developed multiple novel approaches in the areas of gastrointestinal, infectious, ophthalmic, and metabolic diseases, majority of which are derived from the work of Enzo Life Sciences. Enzo Therapeutics focuses its activities on developing treatment regimens for diseases and conditions for which treatment options are ineffective. This focus has generated a clinical and preclinical pipeline, as well as approximately 95 patents and patent applications. Products and Services Research Products: The company engages in the development, production, marketing, and sale of life science research reagents worldwide, through two main channels to market: Enzo Life Sciences: Enzo Life Sciences is a positioned as a manufacturer and supplier of reagents, kits and products supplied to customers in Life Sciences Research, Clinical Research and Drug Development. With direct sales operations in the U.S., Switzerland, Germany, the U.K., France and Benelux, Enzo Life Sciences also supports its approximately 9,000 products through a network of distributors. Axxora.com: Axxora.com is a distribution platform for original manufacturers of research reagents. Researchers use its marketplace to connect with approximately 40 specialty manufacturers and gain access to 40,000 products. Purchasing groups from universities, research institutes, biotech and pharmaceutical companies utilize this catalog to source research reagents and conveniently consolidate orders. Enzo: The original Enzo brand products and technologies are primarily focused in the areas of microarray analysis, gene regulation and gene modification. Alexis: The Alexis brand provides recognition in producing and commercializing reagents and as a source for a comprehensive panel of products in research areas, including the fields of cell death, nitric oxide, and obesity/adipogenesis. Biomol International: The Biomol International brand provides recognition in the cellular biochemistry segment with an emphasis on areas related to protein post-translational modification. Assay Designs: The Assay Designs brand emphasizes its immunoassay development capability in the fields of inflammation, steroids and hormones, and cell signaling. Stressgen: The Stressgen brand is focused on the fields of the heat shock and cell stress. Clinical Laboratory Services The company o

Page 12Next Page
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EZB:GR €2.57 EUR -0.039

EZB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
NanoString Technologies Inc $15.06 USD -0.21
NeoGenomics Inc $5.18 USD -0.34
Pacific Biosciences of California Inc $5.20 USD -0.21
Psychemedics Corp $14.49 USD -0.02
Response Genetics Inc $0.27 USD -0.0312
View Industry Companies
 

Industry Analysis

EZB

Industry Average

Valuation EZB Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.4x
Price/Book 3.9x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ENZO BIOCHEM INC, please visit www.enzo.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.